Viewing nowCombinationLometan Tablets 5/20 mg
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 201405132 · Approved 2014.11.03 · Insurance code 671704370
Improvement of hypertension control in essential hypertension
This medication is used for patients with essential hypertension who do not have sufficient blood pressure control with monotherapy of amlodipine or olmesartan medoxomil. It effectively lowers blood pressure and reduces the burden on the heart and blood vessels. This helps decrease the risk of complications and aids in stable management of blood pressure. It should be used appropriately depending on the patient's blood pressure control status to improve hypertension.
This medication is taken once daily, with or without food, alongside water. It is recommended to take it at the same time every day (e.g., in the morning). The recommended dosages are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled by monotherapy of amlodipine 5 mg or olmesartan medoxomil 20 mg. - 10/20 mg: For patients not adequately controlled by olmesartan medoxomil 20 mg.
Safety and efficacy have not been established for pediatric patients under 18 years of age.
This medication can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to the active ingredients or similar components, pregnant or nursing women, patients with severe liver impairment, severe aortic stenosis, biliary obstruction, patients on renal dialysis, patients in shock, certain diabetic patients, and patients with severe renal impairment should not be administered this medication. In patients with low blood pressure due to a lack of fluids or salts, careful monitoring is required when administering this medication for the first time, as symptoms of low blood pressure may occur, and appropriate action is needed in such cases. Since this medication has a vasodilatory effect, it should be administered with caution in patients with severe aortic stenosis, obstructive coronary artery disease, and congestive heart failure. It may affect kidney function, so patients with renal impairment or renal artery stenosis should be monitored closely. Since this medication is metabolized in the liver, caution is also needed when administering it to patients with liver impairment. During the use of this medication, adverse reactions such as dizziness, headache, hypotension, orthostatic hypotension, edema, dyspepsia, rash, etc. may occur, and if these symptoms are severe, consultation with a professional is necessary. It is generally advised not to use this medication during pregnancy, and if planning to become pregnant or currently pregnant, consultation with a doctor is essential. Nursing mothers are recommended to either discontinue breastfeeding or stop taking this medication, as it may cause adverse reactions in infants. Safety and efficacy of this medication have not been established in patients under 18 years of age, and it is not recommended for this group. In elderly patients, it is recommended to start at a low dose and monitor closely, considering the potential decline in renal and liver function. In case of overdose, symptoms such as hypotension and tachycardia may occur; therefore, seek appropriate treatment promptly by visiting the hospital. This medication should be stored in a tightly closed container, away from moisture, heat, and direct sunlight, in a location out of reach of children.
Hives, severe swelling (edema), severe allergic reactions, difficulty breathing (dyspnea), angioedema, jaundice, elevated liver enzymes, acute renal failure, increased blood creatinine, gallstones, exacerbation of cerebrovascular accidents, gum bleeding, toxic epidermal necrolysis.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.
White, round film-coated tablets
28 tablets/box [14 tablets/PTP×2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.